Twenty-Five Years of Contemplating Genotype-Based Hereditary Hemochromatosis Population Screening
Open Access
Abstract
Hereditary hemochromatosis (HH) is a rather frequent, preventable disease because the progressive iron overload affecting many organs can be effectively reduced by phlebotomy. Even before the discovery of the major gene, HFE, in 1996, hemochromatosis was seen as a candidate for population-wide screening programmes. A US Centers of Disease Control and the National Human Genome Research Institute expert panel convened in 1997 to consider genotype-based HH population-wide screening and decided that the scientific evidence available at that time was insufficient and advised against. In spite of a large number of studies performed within the last 25 years, addressing all aspects of HH natural history, health economics, and social acceptability, no professional body worldwide has reverted this decision, and HH remains a life-threatening condition that often goes undetected at a curable stage.Keywords
This publication has 53 references indexed in Scilit:
- ironXS: high-school screening for hereditary haemochromatosis is acceptable and feasibleEuropean Journal of Human Genetics, 2012
- Diagnosis and management of hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver DiseasesHepatology, 2011
- HFE C282Y Homozygosity Is Associated With Lower Total and Low-Density Lipoprotein CholesterolCirculation: Cardiovascular Genetics, 2009
- HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) StudyTranslational Research, 2008
- Hemochromatosis and Iron-Overload Screening in a Racially Diverse PopulationNew England Journal of Medicine, 2005
- Attitudes about and Psychosocial Outcomes of HFE Genotyping for HemochromatosisGenetic Testing, 2004
- Genetic Testing for Hemochromatosis: Attitudes and Acceptability among Young and Older AdultsGenetic Testing, 2003
- Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USAThe Lancet, 2002
- A Population-Based Study of the Clinical Expression of the Hemochromatosis GeneNew England Journal of Medicine, 1999
- Haemochromatosis gene C282Y homozygotes in an elderly male populationThe Lancet, 1999